{"count": 3, "results": [{"_id": "21561700", "pmid": 21561700, "title": "[Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].", "journal": "Rev Esp Cardiol", "authors": ["Forteza A", "Evangelista A", "Sánchez V", "Teixidó G", "García D", "Sanz P", "Gutiérrez L", "Centeno J", "Rodríguez-Palomares J", "Cortina J", "García-Dorado D"], "date": "2011-06-01T00:00:00Z", "doi": "10.1016/j.recesp.2011.02.009", "meta_date_publication": "2011 Jun", "meta_volume": "64", "meta_issue": "6", "meta_pages": "492-8", "score": 50058.35, "text_hl": "CONCLUSIONS: Efficacy of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in the prevention of progressive @DISEASE_Cardiomyopathy_Dilated @DISEASE_MESH:D002311 @@@dilation of the aorta@@@, improved aortic distensibility, and prevention of adverse events (@<m>DISEASE_Aortic_Dissection</m> @DISEASE_MESH:D000784 @@@aortic dissection or rupture@@@, cardiovascular surgery, or @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@) will be assessed in this study. ", "citations": {"NLM": "Forteza A, Evangelista A, Sánchez V, Teixidó G, García D, Sanz P, Gutiérrez L, Centeno J, Rodríguez-Palomares J, Cortina J, García-Dorado D. [Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome]. Rev Esp Cardiol. 2011 Jun;64(6):492-8. PMID: 21561700", "BibTeX": "@article{21561700, title={[Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].}, author={Forteza A and Evangelista A and Sánchez V and Teixidó G and García D and Sanz P and Gutiérrez L and Centeno J and Rodríguez-Palomares J and Cortina J and García-Dorado D}, journal={Rev Esp Cardiol}, volume={64}, number={6}, pages={492-8}}"}}, {"_id": "2895838", "pmid": 2895838, "title": "Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group.", "journal": "Lancet", "date": "1988-04-23T00:00:00Z", "meta_date_publication": "1988 Apr 23", "meta_volume": "1", "meta_issue": "8591", "meta_pages": "921-3", "score": 50050.32, "text_hl": "There was a slightly higher incidence of fatal @DISEASE_Ventricular_Fibrillation @DISEASE_MESH:D014693 @@@ventricular fibrillation@@@ and @<m>DISEASE_Aortic_Dissection</m> @DISEASE_MESH:D000784 @@@aortic dissection@@@ in the control group, and of @DISEASE_Bradycardia @DISEASE_MESH:D001919 @@@bradycardia@@@/@DISEASE_Heart_Arrest @DISEASE_MESH:D006323 @@@asystole@@@ in the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group. ", "citations": {"NLM": "Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Lancet. 1988 Apr 23;1(8591):921-3. PMID: 2895838", "BibTeX": "@article{2895838, title={Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group.}, journal={Lancet}, volume={1}, number={8591}, pages={921-3}}"}}, {"_id": "30115424", "pmid": 30115424, "title": "Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome.", "journal": "Am J Cardiol", "authors": ["Mah DY", "Sleeper LA", "Crosson JE", "Czosek RJ", "Love BA", "McCrindle BW", "Muiño-Mosquera L", "Olson AK", "Pilcher TA", "Tierney ESS", "Shah MJ", "Wechsler SB", "Young LT", "Lacro RV"], "date": "2018-10-15T00:00:00Z", "doi": "10.1016/j.amjcard.2018.07.006", "meta_date_publication": "2018 Oct 15", "meta_volume": "122", "meta_issue": "8", "meta_pages": "1429-1436", "score": 50036.777, "text_hl": "Data from the Pediatric Heart Network randomized trial of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ versus @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ in @DISEASE_Marfan_Syndrome @DISEASE_MESH:D008382 @@@MFS@@@ were analyzed (6 months to 25 years old, aortic root diameter z-score > 3.0, no previous aortic surgery and/or @<m>DISEASE_Aortic_Dissection</m> @DISEASE_MESH:D000784 @@@dissection@@@). ", "citations": {"NLM": "Mah DY, Sleeper LA, Crosson JE, Czosek RJ, Love BA, McCrindle BW, Muiño-Mosquera L, Olson AK, Pilcher TA, Tierney ESS, Shah MJ, Wechsler SB, Young LT, Lacro RV. Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome. Am J Cardiol. 2018 Oct 15;122(8):1429-1436. PMID: 30115424", "BibTeX": "@article{30115424, title={Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome.}, author={Mah DY and Sleeper LA and Crosson JE and Czosek RJ and Love BA and McCrindle BW and Muiño-Mosquera L and Olson AK and Pilcher TA and Tierney ESS and Shah MJ and Wechsler SB and Young LT and Lacro RV}, journal={Am J Cardiol}, volume={122}, number={8}, pages={1429-1436}}"}}]}